title: Validating benefit of biomarker-directed therapy for acute kidney injury: can you have your cake and eat it?
authors.affiliation: Adult Critical Care Unit and Department of Renal Medicine and Transplantation, The Royal London Hospital, Barts Health NHS Trust, Whitechapel Road, London, E1 1BB, UK. j.prowle@qmul.ac.uk.|William Harvey Research Institute, Queen Mary University of London, London, UK. j.prowle@qmul.ac.uk.
authors.forename: J R
authors.initials: JR
authors.lastname: Prowle
authors.affiliation: Division of Cellular and Molecular Medicine, Clinical Department and Laboratory of Intensive Care Medicine, KU Leuven University, Herestraat 49, 3000, Leuven, Belgium.
authors.forename: M
authors.initials: M
authors.lastname: Schetz
mesh_terms: D058186:Acute Kidney Injury; D015415:Biomarkers; D006801:Humans
chemical_list: D015415:Biomarkers